Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients

BACKGROUND: The measurement of ESR1 and PIK3CA mutations in plasma cell-free DNA (cfDNA) has been studied as a non-invasive method to quickly assess and monitor endocrine therapy (ET) resistant metastatic breast cancer (MBC) patients. METHODS: The subjects of this retrospective study were a total of...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeshita, Takashi, Yamamoto, Yutaka, Yamamoto-Ibusuki, Mutsuko, Tomiguchi, Mai, Sueta, Aiko, Murakami, Keiichi, Omoto, Yoko, Iwase, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581019/
https://www.ncbi.nlm.nih.gov/pubmed/28881720
http://dx.doi.org/10.18632/oncotarget.18479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581019/
https://www.ncbi.nlm.nih.gov/pubmed/28881720
http://dx.doi.org/10.18632/oncotarget.18479

Ejemplares similares